You Position: Home > Paper

Evolution of sequential bortezomib-dexamethasone treatment followed by autologous hematopoietic stem cell transplantation in hemodialysis treatment

( views:377, downloads:8 )
Author:
No author available
Journal Title:
Chinese Medical Journal
Issue:
9
DOI:
10.3760/cma.j.issn.0366-6999.20130532
Key Word:
No keyword available

Abstract: To the editor:We read with interest the article of Zheng et al1 on sequential treatment with bortezomib plus dexamethasone followed by autologous hematopoietic stem cell transplantation (ASCT) in patients with multiple myeloma (MM).Nephrologists are interested in the treatment of acute renal failure (ARF) in the course of MM because the survival of patients is affected by the recovery of normal renal function,not only for the specific complications of ARF but also for the reduced opportunities for access to more effective drug treatments.To date,the evolution of renal disorders associated with monoclonal light chains in MM remain poorly defined.

WanfangData CO.,Ltd All Rights Reserved
About WanfangData | Contact US
Healthcare Department, Fuxing Road NO.15, Haidian District Beijing, 100038 P.R.China
Tel:+86-010-58882616 Fax:+86-010-58882615 Email:yiyao@wanfangdata.com.cn